Protagonist Therapeutics Incis A Biopharmaceutical Company Based In Newarkcaliforniafounded In 2006The Company Focuses On Developing Peptide Based New Chemical Entities For Various Diseasesparticularly In Hematologyblood Disordersand Inflammatory Conditionsprotagonist Therapeutics Has Been Publicly Traded Since Its Ipo In August 2016 The Company Employs A Peptide Technology Platform To Create Drug Candidates That Target Complex Biological Pathwaysthis Technology Supports The Development Of Therapeutics With Specific Properties Such As Potency And Metabolic Stabilityprotagonist S Pipeline Includes Several Candidatessuch As Rusfertide For Polycythemia Verajnj 2113 For Plaque Psoriasis And Ulcerative Colitisand Pn 943 For Moderate To Severe Ulcerative Colitisthe Company Has A Partnership With Janssen Biotech For The Co Development Of Some Of Its Pipeline Candidatesprotagonist Therapeutics Is Led By President And Ceo Dinesh Patel And Has A Team Of Approximately 126 Employees
No conferences found for this company.
| Company Name | Protagonist Therapeutics Inc |
| Country |
United States
|
| Address | 7707 Gateway Boulevard Suite 140 Newark Ca 94560 1160 Usa |
| Telephone | Login to View |
| Login to View |
